LakeShore Biopharma Co

Company snapshot

LakeShore Biopharma Co is a biotech organization headquartered in DAXING DISTRICT, BEIJING, F4, USA. It trades on NYSE under ticker LSBCF. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Profile assembled from SEC, FDA, ClinicalTrials.gov, and USPTO public sources.

Public regulatory, clinical, patent, and corporate records for LakeShore Biopharma Co. Not investment advice.

• What is LakeShore Biopharma Co?

  LakeShore Biopharma Co is a biotech organization headquartered in DAXING DISTRICT, BEIJING, F4, USA. It trades on NYSE under ticker LSBCF. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov

• Is LakeShore Biopharma Co publicly traded?

  Yes. LakeShore Biopharma Co is listed with ticker LSBCF on NYSE per SEC EDGAR records linked on this profile.

• What drugs does LakeShore Biopharma Co develop or market?

  No drug profiles are currently linked to LakeShore Biopharma Co. Pipeline programs may still list investigational assets.

• What are the latest developments for LakeShore Biopharma Co?

  Browse related news and pipeline sections on this page for coverage and ClinicalTrials.gov-linked program updates.

• What therapeutic areas does LakeShore Biopharma Co focus on?

  No specific therapeutic focus areas are currently identified for LakeShore Biopharma Co in our database.